Research News
New Once Weekly Investigational Oral Regimen Shows Strong 48 Week Results, Highlighting the Need for Easier HIV Treatment Options
A Phase 2 study led by Dr. Joe Eron, chief of the Division of Infectious diseases and a member of the UNC Institute for Global Health and Infectious Diseases (IGHID), shows an investigational once‑weekly, all‑oral combination of islatravir (ISL) and lenacapavir(LEN) maintains high levels of virologic suppression through 48 weeks in adults living with HIV. … Read more
Investigators lead study to understand earliest effects of Type 1 Diabetes in young childrenJanice Hwang, MD, MHS, chief of the UNC Division of Endocrinology and Metabolism, is a Principal Investigator for BRAINY-T1D along with Drs. Aysenil Belger and Nina Jain. BRAINY-T1D is a nationwide effort aimed at understanding the earliest effects of Type 1 Diabetes in young children. Spanning eleven campuses from UC Davis to UNC-Chapel Hill, the … Read more
Sheikh and team publish guide for conducting CAR T-cell trials for patients with SLESaira Sheikh, MD Chimeric antigen receptor (CAR) T-cell therapies, best known for its cancer-treating abilities, are being explored as an option for managing autoimmune rheumatic diseases. A team of investigators, including Saira Sheikh, MD, published a guide in ACR Open Rheumatology, providing a detailed exploration of the framework required for rheumatologists to initiate and successfully … Read more
Investigators named to Clarivate’s 2025 Highly Cited ResearchersAnnually, Clarivate releases a list of scientists who demonstrate significant and broad influence in their field(s) of research. The following UNC Department of Medicine faculty were recognized for their work in 2025: John Buse, MD, PhD, Verne S. Caviness Distinguished Professor of Medicine in the Division of Endocrinology (Category: Clinical Medicine) Lisa Carey, MD, L. … Read more
Hwang to Lead UNC Center for Diabetes and Metabolic Health, Funding by NIDDK RenewedDiabetes and obesity are two of the most pressing health challenges in North Carolina. More than 1 million North Carolinians live with diabetes, and over 2 million struggle with obesity. Diabetes is a leading cause of blindness, kidney failure, amputations, and cardiovascular disease, significantly shortening lives and contributing billions of dollars in health care costs. … Read more
UNC Health, Blue Cross NC Study Offers Clinical Evidence on How Food Delivery Models Can Reduce Food Insecurity and Improve Health OutcomesUNC researchers, including Seth Berkowitz, MD, MPH, and Darren DeWalt, MD, MPH, found that a monthly $40 food subsidy improved blood pressure among people facing food insecurity. The results were published in JAMA Internal Medicine. A first-of-its-kind clinical study shows that offering modest monthly grocery cards for produce leads to improvements in blood pressure compared … Read more
Evan Dellon Leads Phase 3 Trial on Cendakimab for Eosinophilic EsophagitisEvan Dellon, MD, MPH, a Professor in the Division of Gastroenterology and Hepatology at UNC and the Director of the Center for Esophageal Diseases and Swallowing, led a Phase 3 Trial on using Cendakimab for Eosinophilic Esophagitis (EoE). His study was published in NEJM Evidence with positive findings. Cendakimab is a high-affinity monoclonal antibody that … Read more
Sheikh, Lee & Niethammer Receive $4.4 Million 2-Year NIH Award to Advance Multi-Modal Machine Learning for Earlier Diagnosis of LupusFrom left to right: Saira Sheikh, MD, Yueh Lee, MD, PhD, Marc Niethammer, PhD A rheumatologist, neuroradiologist, and computer scientist have joined forces to blend medical expertise with AI/machine learning to reimagine the future of lupus diagnosis and care. Saira Sheikh, MD, the Linda Coley Sewell Distinguished Professor of Medicine at UNC and Chair of … Read more
John Buse Co-Publishes ‘STEP UP T2D’ on the Efficacy of Higher Semaglutide DosesJohn Buse, MD, the Verne S. Caviness Distinguished Professor of Medicine and Director of the UNC Diabetes Care Center, co-authored STEP UP T2D an international trial. STEP UP T2D found that a higher maintenance dose of semaglutide (7.2 mg once weekly) leads to significantly greater weight loss and improved blood sugar control in adults with … Read more
Center for Gastrointestinal Biology and Disease Receives 40th Consecutive Year of NIH FundingPictured are Dr. Robert Sandler and Julianne O’Daniel. Robert Sandler, MD, MPH, Professor of Medicine at the University of North Carolina at Chapel Hill and Director of the Center for Gastrointestinal Biology and Disease (CGIBD), has announced the renewal of the Center’s P30 Center grant from the National Institute of Diabetes and Digestive and Kidney … Read more
Gaurav Dave to serve as Research Director for NIH’s Building Interdisciplinary Research Careers in Women’s Health ProgramUNC-Chapel Hill has been announced as the recipient of a National Institutes of Health (NIH) Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) award. Created by the Office of Research on Women’s Health in partnership with NIH Institutes, Centers, and Offices, BIRCWH is a mentored career-development program designed to connect junior faculty to senior faculty … Read more
Shehzad Sheikh Identifies CADM1 as a Key Driver of Gut Inflammation in IBD PatientsShehzad Z. Sheikh, MD, PhD A groundbreaking study co-led by Shehzad Z. Sheikh, MD, PhD, professor of medicine in the UNC Division of Gastroenterology and Hepatology, and Matthew N. Poy, PhD, associate professor of medicine with Johns Hopkins University, reveals Cell Adhesion Molecule 1 (CADM1), a surface protein involved in cell-cell adhesion, is significantly elevated … Read more